# Japanese Foundation For Cancer Research

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/japanese-foundation-for-cancer-research/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 66 |
| Citations | 1,126,409 |
| City | Tokyo |
| Country | JP |
| Description | Japanese Foundation For Cancer Research is a research organisation in Tokyo, JP. OpenAlex records 10,816 works and 1,126,409 citations for it. 2,061 researchers list it as their most recent affiliation. |
| Homepage | http://www.jfcr.or.jp/english/ |
| OpenAlex ID | https://openalex.org/I42570316 |
| Researchers | 2,061 |
| ROR ID | https://ror.org/00bv64a69 |
| Type | nonprofit |
| Wikidata ID | https://www.wikidata.org/wiki/Q11264698 |
| Works | 10,816 |

## University papers

Showing 12 of 19.

- [Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)](https://scholariq.org/papers/tokyo-guidelines-2018-diagnostic-criteria-and-severity-grading-of-acute/)
- [EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors](https://scholariq.org/papers/eml4-alk-mutations-in-lung-cancer-that-confer-resistance-to-alk-inhibitors/)
- [Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis](https://scholariq.org/papers/tokyo-guidelines-2018-flowchart-for-the-management-of-acute-cholecystitis/)
- [Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)](https://scholariq.org/papers/tokyo-guidelines-2018-diagnostic-criteria-and-severity-grading-of-acute-2/)
- [Somatic RHOA mutation in angioimmunoblastic T cell lymphoma](https://scholariq.org/papers/somatic-rhoa-mutation-in-angioimmunoblastic-t-cell-lymphoma/)
- [CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study](https://scholariq.org/papers/ch5424802-ro5424802-for-patients-with-alk-rearranged-advanced-non-small-cell/)
- [Frequent inactivation of A20 in B-cell lymphomas](https://scholariq.org/papers/frequent-inactivation-of-a20-in-b-cell-lymphomas/)
- [Intelligent Image-Activated Cell Sorting](https://scholariq.org/papers/intelligent-image-activated-cell-sorting/)
- [Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos)](https://scholariq.org/papers/tokyo-guidelines-2018-surgical-management-of-acute-cholecystitis-safe-steps-in/)
- [Tokyo Guidelines 2018: Initial Management of Acute Biliary Infection and Flowchart for Acute Cholangitis](https://scholariq.org/papers/tokyo-guidelines-2018-initial-management-of-acute-biliary-infection-and/)
- [Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis](https://scholariq.org/papers/tokyo-guidelines-2018-antimicrobial-therapy-for-acute-cholangitis-and/)
- [Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)](https://scholariq.org/papers/practice-of-endoscopy-during-covid-19-pandemic-position-statements-of-the-asian/)

## University top topics

Showing 8 of 25.

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.